Barclays’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Sell |
14,917
-89,722
| -86% | -$6.47M | ﹤0.01% | 2676 |
|
|
2025
Q4 | $6.68M | Sell |
104,639
-380,282
| -78% | -$23.4M | ﹤0.01% | 1995 |
|
|
2025
Q3 | $30.6M | Sell |
484,921
-189,718
| -28% | -$13.2M | 0.01% | 1003 |
|
|
2025
Q2 | $50.4M | Buy |
674,639
+136,114
| +25% | +$10.7M | 0.01% | 708 |
|
|
2025
Q1 | $47.4M | Sell |
538,525
-11,244
| -2% | -$1.06M | 0.01% | 675 |
|
|
2024
Q4 | $50.2M | Buy |
549,769
+234,725
| +75% | +$24.1M | 0.01% | 661 |
|
|
2024
Q3 | $35.3M | Buy |
315,044
+10,695
| +4% | +$1.07M | 0.01% | 812 |
|
|
2024
Q2 | $29.8M | Sell |
304,349
-53,744
| -15% | -$5.33M | 0.01% | 803 |
|
|
2024
Q1 | $35.9M | Sell |
358,093
-18,316
| -5% | -$1.61M | 0.01% | 740 |
|
|
2023
Q4 | $33.8M | Buy |
376,409
+68,478
| +22% | +$5.46M | 0.01% | 838 |
|
|
2023
Q3 | $23.6M | Sell |
307,931
-13,571
| -4% | -$1.13M | 0.01% | 713 |
|
|
2023
Q2 | $26.9M | Buy |
321,502
+186,674
| +138% | +$15.2M | 0.02% | 622 |
|
|
2023
Q1 | $11.4M | Sell |
134,828
-106,292
| -44% | -$9.13M | 0.01% | 1100 |
|
|
2022
Q4 | $19.6M | Buy |
241,120
+46,658
| +24% | +$3.76M | 0.01% | 900 |
|
|
2022
Q3 | $13.8M | Buy |
194,462
+73,809
| +61% | +$6.63M | 0.02% | 736 |
|
|
2022
Q2 | $10.8M | Sell |
120,653
-71,266
| -37% | -$7.38M | 0.01% | 978 |
|
|
2022
Q1 | $21.5M | Sell |
191,919
-38,863
| -17% | -$4.55M | 0.02% | 654 |
|
|
2021
Q4 | $27.9M | Sell |
230,782
-191,859
| -45% | -$21.3M | 0.01% | 806 |
|
|
2021
Q3 | $42.6M | Buy |
422,641
+188,694
| +81% | +$20.8M | 0.02% | 589 |
|
|
2021
Q2 | $27.3M | Buy |
233,947
+15,495
| +7% | +$1.86M | 0.01% | 747 |
|
|
2021
Q1 | $24.1M | Buy |
218,452
+77,974
| +56% | +$8.47M | 0.01% | 725 |
|
|
2020
Q4 | $14.1M | Sell |
140,478
-151,368
| -52% | -$14M | 0.01% | 1006 |
|
|
2020
Q3 | $22.8M | Buy |
291,846
+161,467
| +124% | +$12.2M | 0.01% | 695 |
|
|
2020
Q2 | $9.08M | Sell |
130,379
-173,734
| -57% | -$10.9M | 0.01% | 1022 |
|
|
2020
Q1 | $14.2M | Sell |
304,113
-354,001
| -54% | -$22.7M | 0.01% | 808 |
|
|
2019
Q4 | $52.2M | Buy |
658,114
+180,879
| +38% | +$13.9M | 0.03% | 494 |
|
|
2019
Q3 | $35.2M | Sell |
477,235
-106,913
| -18% | -$7.67M | 0.02% | 591 |
|
|
2019
Q2 | $45.5M | Buy |
584,148
+384,496
| +193% | +$29.2M | 0.03% | 521 |
|
|
2019
Q1 | $15.1M | Buy |
199,652
+17,654
| +10% | +$1.4M | 0.01% | 1000 |
|
|
2018
Q4 | $13.3M | Sell |
181,998
-8,645
| -5% | -$689K | 0.01% | 989 |
|
|
2018
Q3 | $18.2M | Sell |
190,643
-64,985
| -25% | -$6.44M | 0.01% | 905 |
|
|
2018
Q2 | $25.6M | Buy |
255,628
+29,856
| +13% | +$3.15M | 0.02% | 659 |
|
|
2018
Q1 | $23.8M | Buy |
225,772
+115,463
| +105% | +$11.7M | 0.02% | 765 |
|
|
2017
Q4 | $10.2M | Buy |
110,309
+57,875
| +110% | +$5.26M | 0.01% | 1172 |
|
|
2017
Q3 | $4.75M | Sell |
52,434
-55,183
| -51% | -$4.7M | ﹤0.01% | 1575 |
|
|
2017
Q2 | $9.04M | Buy |
107,617
+74,523
| +225% | +$6.01M | 0.01% | 1039 |
|
|
2017
Q1 | $2.67M | Sell |
33,094
-87,146
| -72% | -$6.85M | ﹤0.01% | 1807 |
|
|
2016
Q4 | $9.04M | Buy |
120,240
+47,555
| +65% | +$3.43M | 0.01% | 1003 |
|
|
2016
Q3 | $4.92M | Sell |
72,685
-620,120
| -90% | -$41.6M | 0.01% | 1309 |
|
|
2016
Q2 | $47M | Buy |
692,805
+482,556
| +230% | +$35.5M | 0.06% | 267 |
|
|
2016
Q1 | $15.1M | Buy |
210,249
+169,430
| +415% | +$11.1M | 0.02% | 587 |
|
|
2015
Q4 | $2.73M | Buy |
40,819
+20,450
| +100% | +$1.43M | ﹤0.01% | 1778 |
|
|
2015
Q3 | $1.3M | Sell |
20,369
-30,220
| -60% | -$2.23M | ﹤0.01% | 2480 |
|
|
2015
Q2 | $4.1M | Sell |
50,589
-8,933
| -15% | -$689K | ﹤0.01% | 1658 |
|
|
2015
Q1 | $4.11M | Sell |
59,522
-37,715
| -39% | -$2.72M | ﹤0.01% | 1724 |
|
|
2014
Q4 | $7.29M | Buy |
97,237
+30,136
| +45% | +$2.38M | 0.01% | 1403 |
|
|
2014
Q3 | $5.37M | Sell |
67,101
-6,739
| -9% | -$562K | 0.01% | 1718 |
|
|
2014
Q2 | $6.42M | Sell |
73,840
-120,036
| -62% | -$10.4M | 0.01% | 1515 |
|
|
2014
Q1 | $16.7M | Buy |
193,876
+58,237
| +43% | +$4.77M | 0.02% | 803 |
|
|
2013
Q4 | $10.8M | Sell |
135,639
-29,759
| -18% | -$2.31M | 0.01% | 1197 |
|
|
2013
Q3 | $12.7M | Buy |
165,398
+16,582
| +11% | +$1.28M | 0.02% | 964 |
|
|
2013
Q2 | $10.4M | Buy |
+148,816
| New | +$10.4M | 0.01% | 1043 |
|
Other funds holding EMN
VPM
VCM
Barclays's EMN Position: Q1 2026 in Review
Barclays reduced its Eastman Chemical (EMN) stake by 86% in Q1 2026, selling an estimated $6.47M and leaving 14,917 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2676.
Barclays first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.2M in Q4 2019. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Barclays held 14,917 shares of Eastman Chemical worth $1.14M as of Q1 2026.
- Barclays sold 89,722 Eastman Chemical shares in Q1 2026, an estimated $6.47M.
- Eastman Chemical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2676 holding.
- Barclays first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Eastman Chemical position peaked at $52.2M in Q4 2019.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.